Novel Viral Vector Manufacturing Approach Could Improve Safety of Gene Therapy
Novel Viral Vector Manufacturing Approach Could Improve Safety of Gene Therapy https://pediatricsnationwide.org/wp-content/uploads/2024/08/AAV-1-blue-AdobeStock_94781662-1024x683.jpg 1024 683 Lauren Dembeck https://pediatricsnationwide.org/wp-content/uploads/2021/03/Dembeck_headshot.gifNew AAV proviral plasmid for vector manufacturing has potential to increase patient safety and make gene therapies more affordable, researchers say. Gene therapy is one of the most exciting frontiers in modern medicine, offering potential cures for previously devastating or fatal disorders, such as spinal muscular atrophy and aromatic L-amino acid decarboxylase deficiency. Adeno-associated virus…